BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21718300)

  • 21. Farnesoid X Receptor (FXR) Interacts with Camp Response Element Binding Protein (CREB) to Modulate Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Secretion by Intestinal L Cell.
    Li P; Zhu L; Yang X; Li W; Sun X; Yi B; Zhu S
    Cell Physiol Biochem; 2018; 47(4):1442-1452. PubMed ID: 29940597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.
    Yusta B; Matthews D; Flock GB; Ussher JR; Lavoie B; Mawe GM; Drucker DJ
    Mol Metab; 2017 Jun; 6(6):503-511. PubMed ID: 28580281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line.
    Simpson AK; Ward PS; Wong KY; Collord GJ; Habib AM; Reimann F; Gribble FM
    Diabetologia; 2007 Oct; 50(10):2181-9. PubMed ID: 17643200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
    Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G413-9. PubMed ID: 23275610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells.
    Friedlander RS; Moss CE; Mace J; Parker HE; Tolhurst G; Habib AM; Wachten S; Cooper DM; Gribble FM; Reimann F
    Br J Pharmacol; 2011 May; 163(2):261-71. PubMed ID: 21054345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chylomicrons stimulate incretin secretion in mouse and human cells.
    Psichas A; Larraufie PF; Goldspink DA; Gribble FM; Reimann F
    Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
    Yan X; Li P; Tang Z; Feng B
    BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
    Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
    Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation.
    Kim K; Park M; Lee YM; Rhyu MR; Kim HY
    Arch Pharm Res; 2014; 37(9):1193-200. PubMed ID: 24590628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acids differ in their capacity to stimulate GLP-1 release from the perfused rat small intestine and stimulate secretion by different sensing mechanisms.
    Modvig IM; Kuhre RE; Jepsen SL; Xu SFS; Engelstoft MS; Egerod KL; Schwartz TW; Ørskov C; Rosenkilde MM; Holst JJ
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E874-E885. PubMed ID: 33645250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.
    Potthoff MJ; Potts A; He T; Duarte JA; Taussig R; Mangelsdorf DJ; Kliewer SA; Burgess SC
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G371-80. PubMed ID: 23257920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digestive physiology of the pig symposium: involvement of gut chemosensing in the regulation of mucosal barrier function and defense mechanisms.
    Kaji I; Akiba Y; Kaunitz JD
    J Anim Sci; 2013 May; 91(5):1957-62. PubMed ID: 23345558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents.
    Christiansen CB; Trammell SAJ; Wewer Albrechtsen NJ; Schoonjans K; Albrechtsen R; Gillum MP; Kuhre RE; Holst JJ
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G574-G584. PubMed ID: 30767682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways.
    Burrin D; Stoll B; Moore D
    J Anim Sci; 2013 May; 91(5):1991-2000. PubMed ID: 23729782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
    Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
    Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Avenues in the Regulation of Gallbladder Motility-Implications for the Use of Glucagon-Like Peptide-Derived Drugs.
    Gether IM; Nexøe-Larsen C; Knop FK
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2463-2472. PubMed ID: 30137354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.